Deyell, Rebecca J <br/><br/>
Phase I study of vinblastine and temsirolimus in pediatric patients with recurrent or refractory solid tumors: Canadian Cancer Trials Group Study IND.218.  [electronic resource] 

 -  Pediatric blood & cancer  03 2019 
 - e27540 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1545-5017 
<br/><br/><label>Standard No.: </label>10.1002/pbc.27540  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Canada<br/>Child<br/>Drug Resistance, Neoplasm<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Male<br/>Maximum Tolerated Dose<br/>Neoplasm Recurrence, Local--drug therapy<br/>Neoplasms--drug therapy<br/>Prognosis<br/>Salvage Therapy<br/>Sirolimus--administration & dosage<br/>Survival Rate<br/>Vinblastine--administration & dosage